Nearly Half With Normal Memory Test Scores Have Undiagnosed Cognitive Impairment

“Doing well on a brief cognitive screening test does not necessarily mean that nothing is wrong,” said Brandon Frank, PhD, as a study he led was published showing how often a quick memory test gets early dementia wrong.

Research released in Neurology Open Access on November 11 found that close to half of patients worried about their memory who received a normal result on a widely used 10-minute screen were actually showing signs of mild cognitive impairment or dementia once they completed a more thorough one-hour evaluation.

The research team examined medical records for roughly 1,800 adults treated at a Veterans Affairs memory clinic in Boston from 2017 through 2025. Their average age was 75. Most took the Montreal Cognitive Assessment (MoCA), a widely used quick screen, followed by an in-depth one-hour interview testing memory, language, planning, and problem-solving, alongside questionnaires on depression and anxiety.

The size of the gap surprised even dementia specialists, who have long known brief screens have limits. In patients whose brain imaging revealed amyloid deposits — a protein tied to Alzheimer’s disease — the brief screen understated the severity of their difficulties compared with the longer evaluation roughly one-third of the time.

Normal Scores May Hide Cognitive Issues

  • A normal score on a 10-minute memory test does not rule out early cognitive problems if you or your family have noticed real changes.
  • About 40 percent of people with a “normal” quick-test score actually had mild cognitive impairment (MCI) on the longer evaluation, and about 9 percent had dementia.
  • Roughly 3 in 10 patients had symptoms of depression or anxiety that had never been recorded in their charts — conditions that can themselves affect memory and may be treatable.

Test Catches Issues MoCA Missed

Mild cognitive impairment is a mild loss of memory or other thinking skills that does not interfere with most daily activities or independence. It affects about 12 to 18 percent of people age 60 and older, and about 10 to 15 percent of people with MCI develop dementia each year, according to the study.

Common Memory Test to Diagnose Dementia Often Misses Early Signs of Cognitive Decline
Photo: collector.com.tr

The longer assessment did not just find more disease. About 1 in 10 people whose quick-test scores suggested mild issues actually showed normal memory and thinking on the hour-long evaluation — meaning the short screen can err in both directions.

Each participant’s results were combined with their medical history and how well they managed daily tasks to determine whether they had normal thinking, MCI, or dementia.

Extended assessments can detect problems that brief screens overlook because they sample a broader set of cognitive domains and offer a wider spread of possible results, allowing clinicians to notice small shifts, said James E. Galvin, MD, MPH, a neurology professor and chief of the division of cognitive neurology at the University of Miami Miller School of Medicine, who was not involved in the study.

Measure Finding
Scored “normal” on quick test but had MCI About 40%
Scored “normal” on quick test but had dementia About 9%
Quick test suggested mild issues; longer test was normal About 1 in 10
Amyloid-positive cases made to look milder by quick test About one-third
Undiagnosed depression or anxiety symptoms About 3 in 10
MCI prevalence, people 60 and older 12–18%

Why Early Diagnosis Changes Treatment Options

Early detection means treatment can start when it is most likely to be effective, Galvin said, and it also opens doors to clinical trials. The latest Alzheimer’s drugs, such as lecanemab (Leqembi) and donanemab (Kisunla), are designed for patients at the very beginning of the disease, when the first symptoms emerge.

“If we are not identifying patients at these stages, we may be losing opportunities to evaluate them for potentially beneficial treatments,” Frank said.

There are other reasons to catch changes early, whether or not someone has Alzheimer’s. Memory and thinking problems can stem from treatable conditions such as mood and sleep disorders or medication side effects. Early diagnosis also gives families time to plan, adopt healthy habits, and find ways to preserve independence.

“Even when we cannot cure an underlying disease, there is often a great deal we can do to help patients and their families adapt to cognitive changes,” Frank said.

Quick Screens Remain Valuable Tools

The findings do not mean doctors should abandon brief screening tests; Frank said the 10-minute exams remain valuable tools for deciding who needs a closer look. But a complete neuropsychological evaluation often involves several hours of testing, and because there is a shortage of neuropsychologists, people may wait months for one.

Time is the barrier to longer testing in routine care, Galvin said. Most clinicians do not have an hour to spend, which is why shorter screens were developed in the first place.

“In the perfect world, the one-hour battery could be shortened to fit in busy office settings but still provide the critical information needed to make the most accurate diagnosis,”
Galvin said.

A hopeful result from the research: scores on the hour-long evaluation were roughly equivalent whether participants completed it face-to-face, over video, or on the phone. Frank said this has important implications for expanding access to specialty memory care, particularly for patients in rural communities, those with mobility limitations, or people who depend on others for transportation.

The Caveats Behind the Numbers

The study has limits its own authors acknowledge. It took place at a single memory clinic, and most patients were older white men, so the results need to be repeated in more diverse groups and other settings, Frank said. The researchers also have not yet shown whether the one-hour approach leads to better long-term outcomes for patients.

One strength, though, stands out: the cohort consisted of patients receiving routine care over nearly eight years, not people recruited specifically for research.

Consult a Doctor About Memory Changes

Not everyone with memory concerns needs an hour of testing, Frank said. But if you are worried about changes in your memory or thinking — or those of a loved one — you can ask your healthcare provider about more detailed testing, particularly if concerns continue after a normal screening result.

Many neurologists, memory clinics, and neuropsychologists offer more detailed evaluation even where the specific one-hour battery used in the study is not available. When possible, bring a family member or someone who knows you well to appointments; information about changes in everyday functioning can be highly valuable to clinicians, Frank said.

Where the Debate Goes From Here

Until then, the practical shift is one patients can make themselves: a normal quick-test score is a starting point, not a verdict.

“Perhaps the most important takeaway for patients and their families is that doing well on a brief cognitive screening test does not necessarily mean that nothing is wrong, particularly when someone has noticed changes in their memory, thinking, or ability to manage everyday activities,” Frank said.

References

  • Frank B et al. One-Hour Cognitive Battery Supports Disease Staging in Memory Clinic Practice. Neurology Open Access. November 11, 2026.
Photo of author

Health Desk

Health Desk at Archyde.

SSC Space to Provide Ground Station Services for Curtin University’s Binar CubeSat Missions

Alan Ritchson’s Runner to Stream on Hulu Nov. 27 After Box Office Flop and Critical Success